In order to examine the cytokine production, five mice from both groups were sacrificed at 1, 2, 3, 4, 5, 6, 7, 8 and 10 days after reconstitution. Serum samples from these mice were analysed for the presence of IL-2, IL-4, IL-6, IFN-y and TNF-0. Figure 1A illustrates the IL-6 levels in serum, which increased at day 4 after allogeneic reconstitution. From day 5 onward these IL-6 levels were significantly increased (p < 0.05) compared with the syngeneically reconstituted mice in which no rise in IL-6 levels was seen. Serum IFN-, levels in the allogeneically reconstituted mice increased at day 4 with a peak on day 5 and 6 (Fig. 1B) . On the peak days these levels were significantly higher (p < 0.05) compared with the syngeneically reconstituted group in which no rise of IFN-, was seen. In the allogeneic group, TNF-levels were significantly higher on day 7 only when compared with the syngeneic control (Fig. lC) . IL-2 and IL-4 levels were below the detection limit: <0.1 U/ml (data not shown). Figure 3 the survival (Fig. 4B) . The effect of a single dose of 2/g of rhTNF-was studied after injection on either day -1, 3 or 6. TNF-administration had no effect on the survival (Fig. 3) . Effect of injection of LPS: In vivo injection of LPS is known to induce IL-1, IL-6 and TNF-production in a time dependent fashion. LPS might therefore modulate the course of GVHD. 6 We studied whether injection of LPS at various days after reconstitution influenced the mortality of GVHD in the BALB/c-(C57BL x CBA)F1 strain combination in three independent experiments. In a representative experiment, groups of mice received 100/g LPS either on day -1, 0, 1, 3 or 6 after allogeneic reconstitution. It appeared that the effect of LPS administration was dependent on the time of injection (Fig. 5) . LPS did not enhance GVHD and mortality when injected on day 1, 3 or 6 after reconstitution. The effect appeared stronger when the LPS was administered at a later time point after reconstitution. In contrast, injection of LPS on day -1 appeared to inhibit GVHD. In all experiments, a rather acute GVHD was induced in the non-treated allogeneically reconstituted mice.
Effect of anti-cytokine and anti-cytokine receptor ,nAB" (C57BL x CBA)F1 mice were lethally irradiated, 38 . This indicates that the inhibitory effect of anti-IL-2 and anti-IL-2R mAb was only temporary at the dose tested.
Discussion
The main finding in this study is that in developing acute GVHD the production of IL-6, IFN-and TNF-is significantly increased although IL-2 is the crucial cytokine which acts as a target for intervention studies. Most studies on the role of cytokines in GVHD deal with only one particular cytokine. We studied the role of several cytokines that are potentially involved in GVHD, by cytokine mRNA expression, analysis of cytokines in serum and culture supernatant and by in vivo administration of recombinant cytokines or anti-cytokine and anti-cytokine receptor mAb. These data substantiate the important role that cytokines play in GVHD. 24 In GVHD, a role for IL-1, IL-2, IFN-2 and TNF-('cytokine storm') has been postulated. [4] [5] [6] [7] [8] Since IL-1 is produced in increasing amounts as clinical GVHD progresses, blocking of 1L-1 activity led to strongly enhanced survival from GVHD in mice. 8 38 Also, in human bone marrow transplantation treatment with a monoclonal anti-TNF-0 antibody in combination with cyclosporin was found to be ineffective in preventing GVHD in the majority of cases. 39 It has also been described that specific lesions, e.g. gut lesions, due to GVHD can improve upon anti-cytokine (anti-IFN-2) treatment only, but decreased mortality has not been found. 4'33 It can be speculated that once a GVH reaction has been initiated, a variety of cytokines is released (' cytokine storm') which have overlapping activities based on the degeneracy in the cytokine network. Blocking of the activity of only one particular cytokine will be ineffective in that case. Another possibility is that the local amount of cytokines produced in GVHD is so high that even higher systemic doses are required. Finally, it cannot be excluded that in GVHD cytokines other than those studied here, are involved. Recently, IL-7 was reported to be involved in tumour rejection 4 whereas IL-8 levels were found to be elevated after liver transplantation. 41 The observation that anti-IL-2 mAb so far is the only anti-cytokine mAb that is able to enhance the survival might be explained by the critical role of IL-2 in T cell activation.
were able to reduce the morbidity and mortality of GVHD. It is likely that blockade of the cytokine cascade is most easy during the induction phase. These data point to a critical role for IL-2 as a possible therapeutic target in the prevention of GVH. Preliminary data in humans show also a beneficial effect of anti-IL-2R treatment in GVHD. 42 The results of serum and culture supernatant analyses suggest that, besides IL-2, IL-6, 1FN-y and TNF-are involved as well. The observation that serum IL-6, IFN-2 and TNFlevels are elevated, before symptoms of GVHD become apparent, suggests that careful evaluation of cytokines in serum might be useful for the early detection of GVHD. It has to be stressed, however, that elevation of cytokine levels is not restricted to alloreactivity but occurs also during bacterial and viral infections and that determination of cytokines at present can be used only to support current diagnostic procedures.
